Literature DB >> 218194

Low and high density lipoproteins and chylomicrons as regulators of rate of cholesterol synthesis in rat liver in vivo.

J M Andersen, S D Turley, J M Dietschy.   

Abstract

The steady-state levels of plasma cholesterol carried in high and low density lipoproteins and in chylomicrons were varied over a wide range by use of a constant-infusion technique. After 40 hr, the rates of hepatic cholesterol synthesis and levels of hepatic cholesterol esters were measured and were related to the plasma level of each of the lipoprotein fractions. From the rates of infusion and the steady-state plasma levels attained, the whole animal clearance rates for cholesterol carried in low density and high density lipoproteins and in chylomicrons were calculated to be 0.53, 0.61, and 42.6 ml/hr, respectively. Hepatic cholesterol ester content increased by 0.8 mug/g for each 1.0 mg/dl increase in the steady-state level of plasma low density lipoprotein cholesterol and by 1.4 mug/g for a similar elevation in plasma high density lipoprotein cholesterol. In contrast, the increase in ester content was 300-fold greater when chylomicrons were infused (330 mug/g). The rate of hepatic cholesterol synthesis was inhibited by a factor of 0.004 and 0.007, respectively, per 1.0 mg/dl increase in the steady-state level of plasma cholesterol carried in either low density or high density lipoprotein but the inhibition was by a factor of 0.255, 50-fold greater, when chylomicrons were infused. Thus, in the steady state, cholesterol carried in either low density or high density lipoproteins is apparently taken up by the liver and regulates the rate of hepatic cholesterol synthesis; however, cholesterol carried in chylomicrons is at least 50-fold more effective in this regard. This marked difference can be attributed to the much higher rates of transport of chylomicron cholesterol into the hepatocyte than of cholesterol carried in either low density or high density plasma lipoproteins.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218194      PMCID: PMC382897          DOI: 10.1073/pnas.76.1.165

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Receptor-mediated control of cholesterol metabolism.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1976-01-16       Impact factor: 47.728

2.  Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteins and of rat chylomicron remnants.

Authors:  J M Andersen; J M Dietschy
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

3.  Catabolism of the apoprotein of low density lipoproteins by the isolated perfused rat liver.

Authors:  G Sigurdsson; S P Noel; R J Havel
Journal:  J Lipid Res       Date:  1978-07       Impact factor: 5.922

Review 4.  The LDL pathway in human fibroblasts: a receptor-mediated mechanism for the regulation of cholesterol metabolism.

Authors:  J L Goldstein; M S Brown
Journal:  Curr Top Cell Regul       Date:  1976

5.  Regulation of sterol synthesis in adrenal gland of the rat by both high and low density human plasma lipoproteins.

Authors:  J M Andersen; J M Dietschy
Journal:  Biochem Biophys Res Commun       Date:  1976-10-04       Impact factor: 3.575

6.  Surgical management of life-threatening ventricular arrhythmias in patients with coronary artery disease.

Authors:  W B Ricks; R A Winkle; N E Shumway; D C Harrison
Journal:  Circulation       Date:  1977-07       Impact factor: 29.690

7.  Regulation of sterol synthesis in 16 tissues of rat. I. Effect of diurnal light cycling, fasting, stress, manipulation of enterohepatic circulation, and administration of chylomicrons and triton.

Authors:  J M Andersen; J M Dietschy
Journal:  J Biol Chem       Date:  1977-06-10       Impact factor: 5.157

8.  Characterization of the sinusoidal transport process responsible for uptake of chylomicrons by the liver.

Authors:  B C Sherrill; J M Dietschy
Journal:  J Biol Chem       Date:  1978-03-25       Impact factor: 5.157

9.  Lipoprotein-mediated regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesteryl ester metabolism in the adrenal gland of the rat.

Authors:  S Balasubramaniam; J L Goldstein; J R Faust; G Y Brunschede; M S Brown
Journal:  J Biol Chem       Date:  1977-03-10       Impact factor: 5.157

10.  The mechanisms of and the interrelationship between bile acid and chylomicron-mediated regulation of hepatic cholesterol synthesis in the liver of the rat.

Authors:  F O Nervi; J M Dietschy
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

View more
  7 in total

1.  Receptor-independent low density lipoprotein transport in the rat in vivo. Quantitation, characterization, and metabolic consequences.

Authors:  D K Spady; S D Turley; J M Dietschy
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

2.  On the mechanism of the modulation in vitro of acyl-CoA:cholesterol acyltransferase by progesterone.

Authors:  S Synouri-Vrettakou; K A Mitropoulos
Journal:  Biochem J       Date:  1983-10-01       Impact factor: 3.857

Review 3.  Apolipoprotein E.

Authors:  V I Zannis; J L Breslow
Journal:  Mol Cell Biochem       Date:  1982-01-16       Impact factor: 3.396

4.  Effects of Triton WR 1339 and orotic acid on lipid metabolism in rats.

Authors:  N Takeuchi; M Murase; Y Nomura; H Takase; K Uchida
Journal:  Lipids       Date:  1987-08       Impact factor: 1.880

5.  Effect of polyestradiol on lecithin: cholesterol acyltransferase in male and female rats.

Authors:  J M Gandarias; M Lacort; B Ochoa; M Quiroga
Journal:  Lipids       Date:  1981-06       Impact factor: 1.880

6.  Cholesteryl ester hydrolysis in rat liver cytosol. Modulation by female sex hormones.

Authors:  J M Gandarias; M Lacort; B Ochoa
Journal:  Lipids       Date:  1984-12       Impact factor: 1.880

Review 7.  The metabolic basis of familial hypercholesterolemia.

Authors:  N B Myant
Journal:  Klin Wochenschr       Date:  1983-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.